Approved Hospital Formulary
Add Formweb to your mobile device
Search results for:
mitoMYcin
mitoMYcin
| Form | Strength |
|---|---|
| POWDER FOR INJECTION, INTRAVENOUS | 5 mg; 20 mg; 40 mg |
Last updated: Apr. 1, 2022
- High Alert: CAUTION: See High-Alert Medication Policy
- Antineoplastic HD PPE and Disposal
- Antineoplastic HD Hazardous Drug Safe Handling Policy
- RCRA: Disposal
- RCRA: Management of Pharmaceutical Waste Policy
- Black Box Warning: Bone marrow suppression; hemolytic uremic syndrome
Mitosol (Mitomycin 0.2 mg ophthalmic kit) is the formulary agent of choice for topical ophthalmic administration.